+
Karpowership Ghana Company Limited has extended its benevolence to the Osu children’s home in Accra ahead of the Christmas festivities.
The company donated food items such as rice, oil, canned fish, beverages among others to the home as part of its Corporate Social Responsibility Projects.
Presenting the items to the Orphanage, the Corporate Communications Specialist of Karpowership Ghana, Sandra Amarquaye explained it is the culture of the company to always give back to society, in order to improve the lives of people.
She said “Christmas is characterized with giving and as a company we are happy to be back here, to put smiles on the faces of these beautiful children’.
Share:
Saint-Herblain (France), December 16, 2020 – Valneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs, today announced the initiation of a Phase 1/2 clinical study for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.
VLA2001 leverages the manufacturing platform of Valneva s licensed Japanese encephalitis vaccine, IXIARO
® and is the first publicly announced inactivated vaccine against COVID-19 to commence clinical development in Europe.
The VLA2001-201 study is a randomized, double blind and placebo-controlled trial evaluating the safety and immunogenicity for three dose levels in approximately 150 healthy adults.
The study will be conducted in study sites across the United Kingdom and is supported by the National Institute for Health Research (NIHR).
Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate – IT Business Net itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.